Provided by Tiger Trade Technology Pte. Ltd.

Mid-America Apartment Communities

122.39
+0.60000.49%
Post-market: 122.390.00000.00%17:01 EDT
Volume:1.27M
Turnover:155.62M
Market Cap:14.33B
PE:32.38
High:124.45
Open:123.38
Low:122.34
Close:121.79
52wk High:169.42
52wk Low:121.22
Shares:117.08M
Float Shares:115.99M
Volume Ratio:1.16
T/O Rate:1.09%
Dividend:6.06
Dividend Rate:4.95%
EPS(TTM):3.78
EPS(LYR):3.78
ROE:7.64%
ROA:3.26%
PB:2.53
PE(LYR):32.38

Loading ...

Mid-America Apartment Communities Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 09

EVP Amber Fairbanks Reports Disposal of Mid America Apartment Communities Inc. Common Shares

Reuters
·
Jan 09

EVP Chief Strategy & Analysis Timothy Argo Reports Disposal of Mid America Apartment Communities Inc. Common Shares

Reuters
·
Jan 09

Mid-America Apartment Is Maintained at Neutral by UBS

Dow Jones
·
Jan 09

MAA price target raised to $134 from $132 at UBS

TIPRANKS
·
Jan 08

Avalonbay Communities Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jan 08

Janney Adjusts Price Target on Mid-America Apartment Communities to $144 From $146, Maintains Buy Rating

MT Newswires Live
·
Jan 08

Milestone Pharmaceuticals Announces Acceptance of Marketing Authorization Application for Etripamil Nasal Spray in PSVT by the European Medicines Agency

GlobeNewswire
·
Jan 06

Robert J. DelPriore, EVP and General Counsel, reports disposal of Mid America Apartment Communities Inc. common shares

Reuters
·
Jan 06

Mid-America Apartment Communities Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jan 06

Humacyte Announces Planned Marketing Authorization Application for Symvess® in Israel

GlobeNewswire
·
Jan 05

Mid-America Apartment Communities Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 30, 2025

Why Is Theriva Biologics Stock Gaining Monday?

Benzinga_recent_news
·
Dec 30, 2025

Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

GlobeNewswire
·
Dec 29, 2025

Mid-America Apartment Communities Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Dec 23, 2025

Avalonbay Communities Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 23, 2025

Mid-America Apartment Communities Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Dec 20, 2025

Avalonbay Communities Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Dec 20, 2025

Avalonbay Communities Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Dec 18, 2025

Mid-America Apartment Communities Raises Quarterly Dividend to $1.53 per Share From $1.515, Payable Jan. 30, 2026, to Holders of Record Jan. 15

MT Newswires Live
·
Dec 18, 2025